SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001570562-22-000149
Filing Date
2022-12-13
Accepted
2022-12-13 08:38:13
Documents
13
Period of Report
2022-12-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eols-20221212.htm   iXBRL 8-K 35548
2 EX-10.1 a1212228kex101.htm EX-10.1 33195
  Complete submission text file 0001570562-22-000149.txt   214157

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eols-20221212.xsd EX-101.SCH 1909
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eols-20221212_lab.xml EX-101.LAB 24831
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eols-20221212_pre.xml EX-101.PRE 13051
7 EXTRACTED XBRL INSTANCE DOCUMENT eols-20221212_htm.xml XML 11069
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Filer) CIK: 0001570562 (see all company filings)

IRS No.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38381 | Film No.: 221458601
SIC: 2834 Pharmaceutical Preparations